Navigation Links
Argos Therapeutics Announces Additional $17.5 Million Of Series E Financing Bringing Total Commitment To $60 Million
Date:11/20/2013

DURHAM, N.C., Nov. 20, 2013 /PRNewswire/ -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that on November 4, 2013, the Company increased the size of its previously announced Series E financing by $17.5 million, bringing the total amount of committed funds from $42.5 million to $60 million.

In August 2013, Argos announced the closing of a $42.5 million Series E financing.  The additional $17.5 million investment represents additional commitments from current Argos investors and one new investor. The funds from the Series E financing will be used to support the Company's ongoing ADAPT pivotal Phase 3 clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC). 

"This funding further strengthens our ability to advance our ADAPT clinical trial.  In addition, the company is now better positioned to consider and pursue a range of options to support our global manufacturing and commercialization plans based on the potential of our Arcelis™ technology platform," said Jeff Abbey, Argos' president and chief executive officer.

About the Arcelis™ Technology Platform
Arcelis is a fully personalized immunotherapy technology that captures mutated and variant antigens that are specific to each patient's disease. It is designed to overcome immunosuppression by producing a durable memory T cell response without adjuvants that may be associated with toxicity. The technology is potentially applicable to a wide range of different cancers and infectious diseases and is designed to overcome many of the manufacturing and commercialization challenges that have impeded other personalized immunotherapies.

The Arcelis process uses only a sma
'/>"/>

SOURCE Argos Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
3. Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response
4. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
5. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
6. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014  As power morcellator lawsuits continue ... Liebhard LLP notes that women in need of ... number of options that do not involve the ... to a report published by The Wall Street ... include a mini-laparotomy and vaginal hysterectomy. Non-surgical options ...
(Date:8/19/2014)... Research and Markets has announced the ... by Technology, by Application & by Region- Global Trends & ... The demand for membranes is estimated to increase at ... $29.31 billion Membrane technology was first commercialized in ... filtration and kidney dialysis. In modern times, membranes find extensive ...
(Date:8/19/2014)... Va. , Aug. 19, 2014 Avizia, ... announced that it has closed an equity financing round ... and Middleland Capital. The new funding will be used ... With this financing round, Avizia welcomes Edward Kennedy ... board of directors. He joins Leonard Kurtzman , ...
Breaking Medicine Technology:As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2
... June 30 If you have been eating Garlic to keep ... there is absolutely no scientific evidence that eating garlic actually keeps ... keeps them away. , , Spraying garlic extract on ... a product from Garlic Research Labs, Inc. is being used successfully ...
... Accumetrics, Inc. announces that it has reached the halfway mark ... GRAVITAS ( G auging R esponsiveness with A ... A nd S afety). The trial is ... actionable information for patients who are poor responders to clopidogrel ...
Cached Medicine Technology:Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2
(Date:8/20/2014)... If old age is a disease then ... With extensive research on HGH and stem cells technology, the ... perfected the art of rubbing off decades from your face ... with their revolutionary anti-aging hormone therapy and regenerative medicine. ... of youth, the MD of MetroMD, Dr Alex Martin said ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Today, Zane ... information on open enrollment for 2015. , According to ... coming up in November, employees are encouraged to start ... coverage in 2015, the open enrollment period will run ... open enrollment 2015 individuals can purchase a new individual ...
(Date:8/20/2014)... Boston, MA (PRWEB) August 20, 2014 ... the annual Inc. 500|5000 list; an exclusive list ranking ... this list are ranked according to their yearly percentage ... marks the 8th time on the Inc. 5000 list ... Experience Technology Company, Verndale offers its clients a wide ...
(Date:8/20/2014)... Oxnard dentist and noted ... Dental Art Institute, is presenting at the Spectrum Day ... speaking on All-on-4 dental implants in a ... Solutions” at 12:40 p.m. Sept. 20 at the Empire ... Canada. , “The All-on-4 procedure gives patients a set ...
(Date:8/20/2014)... No matter how “lonely” a person may be, he ... friends to be always there for them. However, it is ... making new friends during adulthood : not only is ... of one’s family to a near-slavish devotion to career-building, the ... just is not the same as it was when one ...
Breaking Medicine News(10 mins):Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... to leverage Health Integrated,s Synergy Targeted Population Management(R) ... for Medicaid subscribersPORTLAND, Ore. and TAMPA, Fla., March ... provides Medicaid and Medicare managed care services for ... Health Management company, are partnering to improve the ...
... Go Healthy, Inc. (Pink Sheets: GOHE) announced today that the ... Officer for the China Shenyang Company in support of the ... Loan Package.Stuart Evey, Chairman of Go Healthy and formerly the ... see the support of our operating plans and this letter ...
... control may improve neurologic outcomes after stroke or ... top-rated neurology programs cool their critically ill stroke ... and technologically advanced Arctic Sun(R) Temperature Management ... of the 30 top-ranked neurology programs at community ...
... market for further study. Now, after being formally approved for use ... Jersey cosmetic plastic surgeon discusses the reasons why the FDA’s decision ... ... (Vocus) March 25, 2009 -- New statistics from the ...
... awarded to one African-American student of high achievement. Ricky Williams is ... ... March 25, 2009 - Acupuncture & Massage College has established a ... African-American student of high achievement. The first recipient will be Ricky ...
... over several assisted reproduction cycles that use both fresh ... transferring two or more embryos at one time, according ... patients who choose to have only one embryo implanted ... The authors of the Finnish study published online today ...
Cached Medicine News:Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 3Health News:Go Healthy Announces Receipt of Letter of Interest to Fund Distribution, Production, Packaging, Concept Stores and Bottling Facilities 2Health News:Top Neurology Programs Control Fever with Arctic Sun Cooling Technology 2Health News:Top Neurology Programs Control Fever with Arctic Sun Cooling Technology 3Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 2Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 3Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 4Health News:Acupuncture & Massage College Announces Ricky William's Scholarship 2Health News:Acupuncture & Massage College Announces Ricky William's Scholarship 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 2Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 4
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism....
Adult model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 14 mm....
Solid 14 mm blades, suture posts, and canthus bar. Dull finish....
... the E3671 twisted snare wires. The wire is ... the loop can be stopped at any point. ... loop can be slipped down the nerve before ... Comes with one package of E3671 twisted snare ...
Medicine Products: